About Us

Quinten Health, headquartered in Paris, is the French pioneer in artificial intelligence and interpretable data science applied to healthcare since 2008.

Quinten Health provides healthcare stakeholders (industry, hospitals, and regulatory agencies) with AI/ML solutions for precision care specializing in real-world data science services and real-world outcomes simulation. As an expert in predictive medicine and health outcomes simulation, Quinten Health masters a unique combination of analytical techniques, ranging across e.g. advanced statistical modeling, patterns recognition and subgroups discovery and virtual cohort simulations.

By developing in silico disease and care simulation platforms, Quinten Health is turning a decade of experience in disease modeling and real-world data analytics into disease cohort simulators to accelerate, de-risk and maximize the value of drug clinical development, market access, and life cycle management.

Quinten Health establishes and nurtures strategic partnerships with academic research institutions and private enterprises to provide healthcare solutions to healthcare providers and organizations, regulatory agencies and payers, as well as pharmaceutical and medical device companies. Such collaborations can materialize as collaborative projects supported by public grants like Horizon, IHI European projects, and National innovation programs, or as spontaneous partnerships arising from shared business interests and synergies.

Our journey


Quinten creation by three engineers, Mariem, Guillaume, and Alexandre, united by the same vision: data is going to play the central role in organisations.


Quinten collaborates with 20 Big pharma, biotech, and top-notched research institutions.


Start of the strategic partnership with Sanofi around Real world data science.


Quinten becomes a leading expert in leveraging real world data via artificial intelligence and creates the Quinten Health subsidiary to help stakeholders across the healthcare value chain make informed decisions and improve patients care.


Quinten Health closes its financing round to advance disease modeling platforms and real-world virtual twins, as part of the €14 million growth equity investment from TECHLIFE CAPITAL and MACSF.

the leadership team

Alexandre Templier, PhD, MBA
Co-founder and President of Quinten group

Billy Amzal - CEO Quinten Health

Billy Amzal, PhD, MBA
CEO of Quinten Health

Quinten Health is a team of 50+ healthcare data scientists, modelers and biomedical and public health experts.